231 related articles for article (PubMed ID: 28068521)
1. HIV and its relationship to insulin resistance and lipid abnormalities.
Non LR; Escota GV; Powderly WG
Transl Res; 2017 May; 183():41-56. PubMed ID: 28068521
[TBL] [Abstract][Full Text] [Related]
2. Lipodystrophy, insulin resistance, diabetes mellitus, dyslipidemia, and cardiovascular disease in human immunodeficiency virus infection.
Tanwani LK; Mokshagundam SL
South Med J; 2003 Feb; 96(2):180-8; quiz 189. PubMed ID: 12630645
[TBL] [Abstract][Full Text] [Related]
3. Contribution of inflammation to fat redistribution and metabolic disturbances in HIV-1 infected patients.
Stankov MV; Behrens GM
Curr Pharm Des; 2010 Oct; 16(30):3361-71. PubMed ID: 20687889
[TBL] [Abstract][Full Text] [Related]
4. Endocrine and metabolic abnormalities among HIV-infected patients: a current review.
Kibirige D; Ssekitoleko R
Int J STD AIDS; 2013 Aug; 24(8):603-11. PubMed ID: 23970578
[TBL] [Abstract][Full Text] [Related]
5. HIV and antiretroviral therapy: lipid abnormalities and associated cardiovascular risk in HIV-infected patients.
Kotler DP
J Acquir Immune Defic Syndr; 2008 Sep; 49 Suppl 2():S79-85. PubMed ID: 18725816
[TBL] [Abstract][Full Text] [Related]
6. Management of metabolic complications and cardiovascular risk in HIV-infected patients.
Blanco F; San Román J; Vispo E; López M; Salto A; Abad V; Soriano V
AIDS Rev; 2010; 12(4):231-41. PubMed ID: 21179187
[TBL] [Abstract][Full Text] [Related]
7. [Metabolic abnormalities, lipodystrophy and cardiovascular risk in HIV-infected patients].
Leclercq P; Blanc M
Rev Prat; 2006 May; 56(9):987-94. PubMed ID: 16775979
[TBL] [Abstract][Full Text] [Related]
8. Clinical review 153: Lipodystrophy in human immunodeficiency virus-infected patients.
Chen D; Misra A; Garg A
J Clin Endocrinol Metab; 2002 Nov; 87(11):4845-56. PubMed ID: 12414837
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival.
Leonard EG; McComsey GA
Infect Dis Clin North Am; 2005 Sep; 19(3):713-29. PubMed ID: 16102657
[TBL] [Abstract][Full Text] [Related]
10. Clinical management considerations for dyslipidemia in HIV-infected individuals.
Kirchner JT
Postgrad Med; 2012 Jan; 124(1):31-40. PubMed ID: 22314112
[TBL] [Abstract][Full Text] [Related]
11. The role of statins in the setting of HIV infection.
Eckard AR; McComsey GA
Curr HIV/AIDS Rep; 2015 Sep; 12(3):305-12. PubMed ID: 26126687
[TBL] [Abstract][Full Text] [Related]
12. Impaired lipid profile and insulin resistance in a cohort of Austrian HIV patients.
Schulte-Hermann K; Schalk H; Haider B; Hutterer J; Gmeinhart B; Pichler K; Brath H; Dorner TE
J Infect Chemother; 2016 Apr; 22(4):248-53. PubMed ID: 26907935
[TBL] [Abstract][Full Text] [Related]
13. HIV infection and cardiovascular disease.
Hemkens LG; Bucher HC
Eur Heart J; 2014 Jun; 35(21):1373-81. PubMed ID: 24408888
[TBL] [Abstract][Full Text] [Related]
14. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
15. Approach to the human immunodeficiency virus-infected patient with lipodystrophy.
Brown TT
J Clin Endocrinol Metab; 2008 Aug; 93(8):2937-45. PubMed ID: 18685115
[TBL] [Abstract][Full Text] [Related]
16. The basis and management of metabolic abnormalities associated with cardiovascular risk in human immunodeficiency virus infection and its treatment.
Crook M
Ann Clin Biochem; 2007 May; 44(Pt 3):219-31. PubMed ID: 17456292
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
Boccara F
AIDS; 2008 Sep; 22 Suppl 3():S19-26. PubMed ID: 18845918
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral therapy with heart.
Randell P; Moyle G
Am J Ther; 2009; 16(6):579-84. PubMed ID: 19940610
[TBL] [Abstract][Full Text] [Related]
19. [Metabolic alterations in HIV-associated lipodystrophy syndrome].
Valente AM; Reis AF; Machado DM; Succi RC; Chacra AR
Arq Bras Endocrinol Metabol; 2005 Dec; 49(6):871-81. PubMed ID: 16544008
[TBL] [Abstract][Full Text] [Related]
20. The road to success. Long-term prognosis for persons living with HIV in Denmark - time trends and risk factors.
Lohse N
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
